Allison Ruchinskas

716 total citations
4 papers, 369 citations indexed

About

Allison Ruchinskas is a scholar working on Immunology, Cancer Research and Molecular Biology. According to data from OpenAlex, Allison Ruchinskas has authored 4 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Immunology, 2 papers in Cancer Research and 1 paper in Molecular Biology. Recurrent topics in Allison Ruchinskas's work include NF-κB Signaling Pathways (2 papers), Neurological diseases and metabolism (1 paper) and Prion Diseases and Protein Misfolding (1 paper). Allison Ruchinskas is often cited by papers focused on NF-κB Signaling Pathways (2 papers), Neurological diseases and metabolism (1 paper) and Prion Diseases and Protein Misfolding (1 paper). Allison Ruchinskas collaborates with scholars based in United States, Norway and Germany. Allison Ruchinskas's co-authors include Sarah K. Kaufman, Marc I. Diamond, Jaime Vaquer‐Alicea, Apurwa M Sharma, Talitha L. Thomas, David W. Sanders, Timothy M. Miller, Thomas Ciucci, Marita Bosticardo and Vishaka Gopalan and has published in prestigious journals such as Neuron, Immunity and The Journal of Immunology.

In The Last Decade

Allison Ruchinskas

3 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Allison Ruchinskas United States	2	258	188	113	82	57	4	369
Youssef Sibih United States	4	248 1.0×	141 0.8×	130 1.2×	90 1.1×	45 0.8×	7	404
Elisabeth Nikitidou Sweden	5	213 0.8×	183 1.0×	153 1.4×	43 0.5×	41 0.7×	5	369
Swati Naphade United States	12	118 0.5×	182 1.0×	53 0.5×	96 1.2×	86 1.5×	19	416
Chantal Maghames France	6	166 0.6×	214 1.1×	73 0.6×	59 0.7×	150 2.6×	7	433
Tomas Kavanagh Australia	9	189 0.7×	209 1.1×	44 0.4×	55 0.7×	29 0.5×	15	366
Andrea C. Klaver United States	12	196 0.8×	149 0.8×	55 0.5×	47 0.6×	112 2.0×	21	374
Niko-Petteri Nykänen United States	8	215 0.8×	185 1.0×	102 0.9×	91 1.1×	170 3.0×	14	436
Yefei Cai United States	5	241 0.9×	162 0.9×	201 1.8×	44 0.5×	32 0.6×	5	439
Marshall S. Goodwin United States	7	147 0.6×	99 0.5×	97 0.9×	74 0.9×	122 2.1×	9	309
Galina Marsh United States	7	148 0.6×	152 0.8×	100 0.9×	95 1.2×	121 2.1×	8	359

Countries citing papers authored by Allison Ruchinskas

Since Specialization

Citations

This map shows the geographic impact of Allison Ruchinskas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allison Ruchinskas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allison Ruchinskas more than expected).

Fields of papers citing papers by Allison Ruchinskas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allison Ruchinskas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allison Ruchinskas. The network helps show where Allison Ruchinskas may publish in the future.

Co-authorship network of co-authors of Allison Ruchinskas

This figure shows the co-authorship network connecting the top 25 collaborators of Allison Ruchinskas. A scholar is included among the top collaborators of Allison Ruchinskas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allison Ruchinskas. Allison Ruchinskas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Ruchinskas, Allison, et al.. (2024). A20 intrinsically influences human effector T‐cell survival and function by regulating both NF‐κB and JNK signaling. European Journal of Immunology. 54(12). e2451245–e2451245.

2.

Ruchinskas, Allison, et al.. (2024). A20 is a negative regulator of both NF-κB and JNK signaling following T cell receptor stimulation in humans. The Journal of Immunology. 212(1_Supplement). 0213_4454–0213_4454. 1 indexed citations

3.

Chopp, Laura B., Vishaka Gopalan, Thomas Ciucci, et al.. (2020). An Integrated Epigenomic and Transcriptomic Map of Mouse and Human αβ T Cell Development. Immunity. 53(6). 1182–1201.e8. 50 indexed citations

4.

Kaufman, Sarah K., David W. Sanders, Talitha L. Thomas, et al.. (2016). Tau Prion Strains Dictate Patterns of Cell Pathology, Progression Rate, and Regional Vulnerability In Vivo. Neuron. 92(4). 796–812. 318 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact